50% off Premium Yearly

OTCMKTS:EADSY
This summary was created by AI, based on 3 opinions in the last 12 months.
Airbus (EADSY) has received mixed reviews, reflecting both optimism and caution from analysts. The company faces challenges with traffic and safety concerns in the US, alongside a significant backlog exceeding 10 years. Additionally, 20% of its business is derived from European defense contracts, suggesting a diversified portfolio. Recent production issues related to A320 jets have raised doubts about meeting production targets, leading to a temporary dip in shares. However, the long-term outlook remains positive, fueled by strong global demand for new aircraft into the 2030s and a slow, steady upward trend in performance. Despite some hurdles, many experts view Airbus as a solid investment at current levels.
(A Top Pick Aug 19/19, Down 46%) He still likes it. He doesn't know when air traffic will resume, including business travel. A vaccine or herd immunity will encourage travel. Boeing, their biggest competitor, is still struggling with the 737 Max. Hold onto this, because when air traffic returns this stock will easily triple. (Stay away from Boeing.)
The aerospace sector has been hit hard. However, he thinks carriers will need to go to new planes eventually and buyers will avoid Boeing. Yield 0%
They are attracting more buying orders. It is a natural beneficiary of the issues Boeing is having. The purchases are multi-year and the deliveries are multi-year. He thinks they will be okay longer term. He prefers the bigger seats for long haul flights. This is definitely a trade here and an opportunity.
This is a recent acquisition. The backlog of orders for Boeing and Airbus is tremendous. He thinks China will favor Airbus over Boeing in future orders. He thinks the Bombardier acquisition gives them an advantage over Boeing across the fleet. They are also setting up a new maintenance service, which might take over work currently done by the airlines. This is a good extension for a capital goods seller. Yield 1.4%. (Analysts’ price target is €120.57)